CTLA4-Ig Relieves Inflammation in Murine Models of Coxsackievirus B3-Induced Myocarditis

Canadian Journal of Cardiology

Volumn 28, Issue 2, 2012, Pages 239-244

  Han, Bo ^a   Jiang, Honglei ^a   Liu, Zhenhu ^a   Zhang, Yi ^a   Zhao, Lijian ^a   Lu, Kang ^a   Xi, Junfang ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; IMMUNOGLOBULIN; INTERLEUKIN 2; INTERLEUKIN 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; COXSACKIE VIRUS B; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; INFLAMMATION; INOCULATION; MORTALITY; MOUSE; NONHUMAN; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TH1 CELL; TH2 CELL; VIRUS MYOCARDITIS; VIRUS REPLICATION;

ANIMALS; AUTOIMMUNITY; COXSACKIEVIRUS INFECTIONS; CTLA-4 ANTIGEN; CYTOKINES; DISEASE MODELS, ANIMAL; ENTEROVIRUS B, HUMAN; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTORS; INFLAMMATION; MICE; MICE, INBRED BALB C; MYOCARDITIS; MYOCARDIUM;

EID: 84862809333     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2011.11.014     Document Type: Article

References (15)

1. Podack E.R. Execution and suicide: cytotoxic lymphocytes enforce draconian laws through separate molecular pathways. Curr Opin Immunol 1995, 7:11-16.
2. Fuse K., Kodama M., Okura Y., et al. Short-term prognostic value of initial serum levels of interleukin-10 in patients with acute myocarditis. Eur J Heart Fail 2005, 7:109-112.
3. Bluestone J.A. Is CTLA-4 a master switch for peripheral T cell tolerance?. J Immunol 1997, 158:1989-1993.
4. Bouguermouh S., Fortin G., Baba N., Rubio M., Sarfati M. CD28 co-stimulation down regulates Th17 development. PLoS One 2009, 4:e5087.
5. Collins A.V., Brodie D.W., Gilbert R.J., et al. The interaction properties of costimulatory molecules revisited. Immunity 2002, 17:201-210.
6. Frisancho-Kiss S., Nyland J.F., Davis S.E., et al. Cutting edge: T cell Ig mucin-3 reduces inflammatory heart disease by increasing CTLA-4 during innate immunity. J Immunol 2006, 176:6411-6415.
7. Watanabe T., Miyatake T., Kumamoto H., et al. Adenovirus-mediated CTLA4 immunoglobulin G gene therapy in cardiac xenotransplantation. Transplant Proc 2004, 36:2478-2479.
8. Engelhardt J.J., Sullivan T.J., Allison J.P. CTLA-4 overexpression inhibits T cell responses though a CD28-B7-dependent mechanism. J Immunol 2006, 177:1052-1061.
9. Rezkalla S., Kloner R.A., Khatib G., Smith F.E., Khatib R. Effect of metoprolol in acute coxsackievirus B3 murine myocarditis. J Am Coll Cardiol 1988, 12:412-414.
10. Seko Y., Takahashi N., Yagita H., Okumura K., Yazaki Y. Expression of cytokine mRNAs in murine hearts with acute myocarditis caused by coxsackievirus b3. J Pathol 1997, 183:105-108.
11. Djukanovic R. The role of co-stimulation in airway inflammation. Clin Exp Allergy 2000, 30(suppl 1):46-50.
12. Jiang Q., Wu J., Yi S.X., Chen X.W., Luo G.X., He W.F. The study of immune tolerance induced by CTLA4Ig in vitro. J Third Milit Med Coll 2003, 25:1896-1898.
13. Sharpe A.H., Freeman G.J. The B7-CD28 superfamily. Nat Rev Immunol 2002, 2:116-126.
14. Matsui Y., Inobe M., Okamoto H., et al. Blockade of T cell costimulatory signals using adenovirus vectors prevents both the induction and the progression of experimental autoimmune myocarditis. J Mol Cell Cardiol 2002, 34:279-295.
15. Liu W., Gao C., Zhou B.G., Li W.M. Effects of adenovirus-mediated gene transfer of ICOSIg and CTLA4Ig fusion protein on experimental autoimmune myocarditis. Autoimmunity 2006, 39:83-92.